Remove 2026 Remove Leads Remove Safety
article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

The project started on 1 October and is scheduled to complete in September 2026. The post Janssen leads effort to cut waste in digital health devices appeared first on. Photo by Possessed Photography on Unsplash.

Leads 121
article thumbnail

Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly

Pharmaceutical Technology

More significantly, the revised contract secures about 70 million vaccine doses every year from 2023 to 2026 for member states, leaving little space in the market for competitors. This deal, therefore, serves as a threat to other vaccine developers with authorisations for distribution in the EU, including Moderna, Novavax, and Sanofi.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BMS strikes $14bn deal for Karuna Therapeutics

European Pharmaceutical Review

The deal includes Karuna’s lead asset KarXT (xanomeline-trospium), a potential first-in-class treatment for schizophrenia. KarXT targets both the M1 and M4 muscarinic receptors, resulting in a differentiated safety and efficacy profile. This represents a 53 percent premium on Karuna’s closing stock price on 21 December 2023.

article thumbnail

NewAmsterdam Pharma enters merger deal with Frazier Lifesciences

Pharmaceutical Technology

Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company. This pro forma cash balance of nearly $470m is anticipated to offer a cash runway for the merged company through 2026.

Pharma 59
article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

There are emerging trends in oncology, with new chemical entities (NCEs) and antibody-drug conjugates (ADC) leading to increased demand for HPAPI manufacturing capabilities. It’s a collaborative approach from safety, engineering, toxicology, and operations to have the most robust potent compound safety.

Safety 98
article thumbnail

Biologics – manufacturing trends in a modern facility

European Pharmaceutical Review

Liam Dunne, MSD Biotech Site Lead, explains that the site operates at the forefront of science and technology with 15,000L-scale, repeatable, robust manufacturing processes to produce highly sensitive monoclonal antibodies (mAbs). The downstream process ensures cell removal, virus safety, and impurity removal. How does it do this?

article thumbnail

VR Training For Medical Device Maintenance Personnel

Infuse Medical

Brief Overview of the Importance of Medical Device Maintenance Medical device maintenance ensures patient safety, operational efficiency, and regulatory compliance in healthcare settings. Regular maintenance helps prevent device malfunctions that could lead to incorrect diagnoses, treatment delays, or patient harm. billion by 2026.